The Selective Peroxisome Proliferator-Activated Receptor-Delta Agonist Seladelpar Reverses Nonalcoholic Steatohepatitis Pathology by Abrogating Lipotoxicity in Diabetic Obese Mice

Citation

Haczeyni, F, Wang, H, Barn, V et al. 2017, 'The Selective Peroxisome Proliferator-Activated Receptor-Delta Agonist Seladelpar Reverses Nonalcoholic Steatohepatitis Pathology by Abrogating Lipotoxicity in Diabetic Obese Mice', Hepatology Communications, vol. 1, no. 7, pp. 663-674.

Year

2017

Field of Research

  • Gastroenterology And Hepatology

Updated:  16 July 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers